NAD+
Nasal SprayLongevity
CapsuleLongevityIn stock
Low-Dose Naltrexone capsule
A low-dose naltrexone capsule for longevity and wellness programs that want a low-cost, recurring, provider-directed SKU spanning inflammation, autoimmune support, and metabolic goals, on the same intake and refill backend.
Cadence
Nightly
Typical dose
1.5 to 4.5 mg
Format
Low-dose compounded capsule
Routine
Often dosed nightly
Rx required
Yes, licensed provider review
Source
503A compounding pharmacies
About the protocol
A low-cost, cross-category wellness SKU
Naltrexone is an FDA-approved opioid antagonist used at 50 mg for addiction. At roughly one-tenth that dose, commonly 1.5 to 4.5 mg, clinicians use it off-label as low-dose naltrexone for its proposed immune-modulating and anti-inflammatory effects. There is no commercial low-dose product, so LDN must be compounded, which makes it a natural fit for a 503A workflow. Several telehealth platforms have built entire programs around it across chronic pain, autoimmune support, and metabolic health, which is why it has become a popular recurring add for longevity brands.
- Used off-label at a fraction of the standard naltrexone dose for immune and inflammatory goals
- Must be compounded, since no commercial low-dose product exists, which suits a 503A program
- Low cost and a simple nightly routine make it an easy recurring membership SKU
- Evidence is still emerging, so positioning should stay conservative and provider-directed
Mechanism
Brief low-dose opioid-receptor blockade is proposed to modulate immune and inflammatory signaling.
Delivery
A compounded low-dose capsule, commonly taken nightly at a consistent time.
Operations
A simple daily routine fits cleanly into refill reminders and recurring shipments.
Oversight
Provider review covers eligibility, current opioid use, and expectation setting.
Program design
A low-friction recurring layer for a longevity stack
LDN works best as an accessible, low-cost layer that sits alongside higher-touch longevity offers. It is easy to onboard, easy to refill, and broad enough to attract patients with several different goals.
Recurring and low cost
An inexpensive nightly capsule is a clean entry point that supports steady membership retention.
Broad patient interest
Demand spans inflammation, autoimmune support, and metabolic goals, which widens the top of the funnel.
Conservative claims
Because the evidence base is still developing, keep messaging measured and let providers own continuation.
LDN is an off-label, provider-directed use of naltrexone. It is not appropriate for patients using opioids, and screening for that belongs in intake and provider review.
Launch flow
A simple launch flow for low-dose naltrexone
The safest pages keep the workflow clear and let providers own the exact dose and titration. For most teams, the operational value is the nightly routine and refill simplicity.
- 1Step 1Intake and screeningCollect goals, medication history including any opioid use, and contraindications, then route to a licensed provider.
- 2Step 2Low-dose startApprove the order, set a conservative starting dose with optional titration, and coach nightly timing and expectations.
- 3Step 3Refill and continuation checkUse follow-ups to assess tolerability and perceived benefit, and decide whether to continue, adjust, or pause.
Dose and titration vary by clinician and goal, so the public page should lead with the routine and let provider review set the specifics.
Format comparison
Interactive operator view
Compare how a nightly LDN capsule usually behaves operationally versus an injectable longevity protocol. These are planning dimensions, not clinical outcome comparisons.
Format comparison by operator dimension
Hover to compare ldn capsule versus injectable protocol.
LDN capsuleInjectable protocol
Strongest current edge
Refill ease
LDN capsule scores 92/100 on this dimension.
Clearest difference
Cost accessibility
This is where the two NAD+ formats separate the most in program design terms.
Needs the most support
Provider oversight
This is the weakest current score in the comparison, so it is the area most likely to need extra workflow design.
Illustrative operator-planning view based on onboarding, refill behavior, and cost. Not a statement of safety or efficacy.
The Turbopills stack for this program
Everything you need to run an LDN program
Keep your own brand and let the backend handle intake logic, provider review, subscriptions, refill reminders, and patient communications for a low-cost recurring SKU.
Product website & ad landing pages
Turbopills AI Studio — ad images & videos
BetaProvider review & e-Rx
Pharmacy order routing
Refills & auto-ship
Experiments & A/B tests
BetaReady to launch
Launch an LDN offer with a clean operational footprint.
The platform brings the intake, subscriptions, refill flows, billing, and patient messaging. Plug in your licensed providers and pharmacy partners, and your team focuses on positioning and acquisition.
Marketing and educational content only. Clinical details on this page are summarized from publicly available sources to help operators scope a program — they are not medical advice, dosing instructions, or a recommendation for any individual patient. Real patient care requires a licensed provider and a compliant pharmacy partner; Turbopills provides the software that helps brands run the program around them.
Related
